Search for: "PFIZER, INC. (PFIZER)"
Results 1081 - 1100
of 1,505
Sorted by Relevance
|
Sort by Date
10 Feb 2012, 8:39 am
Pfizer, Inc., 835 F. [read post]
23 Jan 2018, 7:29 pm
” Pfizer, Inc. v. [read post]
3 Mar 2020, 4:00 am
Bell Helicopter Textron Canada Limitée, 2012 FC 113 citing Pfizer Canada Inc v Apotex Inc, 2007 FC 971, the Court said it is entitled to look at all the patents and other publications that a skilled technician would discover in a ‘reasonable and diligent search’ to determine whether the resulting ‘mosaic’ leads directly to the invention. [read post]
19 Oct 2009, 4:30 am
Pfizer, Inc., 381 F. [read post]
27 May 2009, 4:09 am
Pfizer Inc. more than doubled its spending on lobbying in the period to $6.1 million.Earlier this month, drug makers joined doctors, insurers and hospitals in a pledge to rein in health-care cost increases by $2 trillion over the next decade. [read post]
9 Jan 2012, 6:24 pm
Mylan, Inc., No. 11:1-cv-03037-MHS (N.D. [read post]
3 Aug 2011, 3:31 am
Paddock (Orange Book Blog) (Holman’s Biotech IP Blog) Cetrorelix – UK: Non-payment of Cetrorelix fee on time fatal for SPC: Case BLO/252/11 The Administrators of the Tulane Education Fund (The SPC Blog) Detrol (Tolterodine tartrate) – US: Pfizer files patent infringement complaint against Torrent Pharma in response to Para IV certification filing (Patent Docs) Galantamine – EU: CJEU ruling in Case C-427/09 Generics (UK) Ltd v Synaptech (The SPC Blog) (EPLAW)… [read post]
9 Dec 2009, 3:00 am
Pfizer, Inc., 2008 WL 2468538 (N.Y. [read post]
5 Aug 2009, 5:35 am
(Spicy IP) Coversyl (Perindopril) – Canada: Court of Appeal upholds Trial Division finding of patent validity and infringement: Apotex v ADIR (Pharmacapsules@Gowlings) Cozaar (Losartan) – France: French Patent Office grants paediatric extension of French SPC for Losartan (The SPC Blog) Cozaar/Hyzaar (Losartan) – US: FDA prevails in generic Cozaar/Hyzaar 180-day exclusivity forfeiture litigation: Teva Pharmaceuticals v Sebelius (FDA Law Blog) Diflucan (Fluconazole)… [read post]
26 Feb 2008, 1:10 am
John McCain and John McCain 2008, Inc. [read post]
26 Jan 2015, 4:00 am
Pfizer, Inc. (2010) 49 Cal.4th 758 in which the Supreme Court held retail pharmacies had standing to assert UCL claims against pharmaceutical companies that had allegedly engaged in price fixing even though the retail pharmacies were able to pass on any overcharges to their customers. [read post]
3 Jul 2007, 6:22 am
Pfizer, Inc., ___ F. [read post]
27 Jun 2013, 10:59 am
Pfizer Canada Inc. 2012 SCC 60 Tremblay v. [read post]
17 Jun 2012, 3:52 pm
Prior to founding RaymondStevenson in 2007, Betsy worked with Pfizer Inc’s Corporate Communications group, where she developed strategy and directed international and top-tier media relations for the company’s Oncology and Central Nervous System portfolios and served as media counsel for Pfizer’s Chief Medical Officer and Senior Vice President Worldwide Development. [read post]
21 Jun 2013, 12:30 pm
’” Pfizer Inc. v. [read post]
23 Jul 2012, 7:33 am
In In re Pfizer Inc. [read post]
30 Sep 2010, 5:58 am
The petitioners have asked the SEC to stay the Nov. 15 effective date of the rules pending conclusion of the litigation.Chief Justice to Hear Pfizer Cases After Selling Company's StockThe Associated PressChief Justice John Roberts has sold his shares of Pfizer Inc., a move that allows him to participate in two pending Supreme Court cases involving the pharmaceutical maker. [read post]
30 Oct 2009, 6:04 am
Axcelis Technologies, Inc., decided September 29, 2009 - involved something of a collateral issue: namely, whether to permit inspection of documents relating to the board's decision to reject the proffered resignations of three directors. [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]